Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases - Harlid - 2022 - International Journal of Cancer - Wiley Online Library
Frontiers | Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
Kaplan-Meier curves for colorectal cancer patients with BRAF-wild-type... | Download Scientific Diagram
Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers | Discover Oncology
IJMS | Free Full-Text | The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
Cancers | Free Full-Text | Conversion Strategy in Left-Sided RAS/BRAF Wild- Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study
![PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/50a4df542bd40adc614a990d8984a44bb22f05b5/3-Figure1-1.png "PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar")
PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar
PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients - Onco Americas
Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology
![PDF] Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/83d238981a0fb4261d1ccb37391284312cb0fd5e/2-Table1-1.png "PDF] Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status | Semantic Scholar")
PDF] Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status | Semantic Scholar
BRAF Mutation and Its Importance in Colorectal Cancer | IntechOpen
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
BRAF mutation and clinical outcome in colon cancer. A-C. Kaplan-Meier... | Download Scientific Diagram
Colorectal Cancer – Treatments | Gastrointestinal Cancer
BRAF Mutation in Colorectal Cancer | IntechOpen
Cancers | Free Full-Text | Targeting BRAF and RAS in Colorectal Cancer
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
Frequencies of RAS/BRAFV600E mutation subtypes. N = 152 (KRAS Exon2... | Download Scientific Diagram
Cureus | Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019 | Article
BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer | Scientific Reports
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
Glimmers of Hope—New Strategies for Overcoming Treatment Resistance in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer - touchONCOLOGY
